Heart 2009;95:709-714
ORIGINAL ARTICLES
Heart rhythm disorders and pacemakers
Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy
1 Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
2 Department of Medicine, and the Division of Pedatric Cardiology, Mayo Clinic, Rochester, Minnesota, USA
3 Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA
Dr P A Brady, Mayo Clinic, Gonda 5 South, 200 First St SW, Rochester, MN 55905, USA; brady.peter{at}mayo.edu
Background: Although the benefit of implantable cardioverter defibrillator (ICD) therapy in patients with hypertrophic cardiomyopathy (HCM) at risk for sudden cardiac arrest is well established, there may be a higher risk for device complications and inappropriate shocks.
Objectives: To determine the incidence of inappropriate ICD shocks and device complications in HCM patients and the impact of young age at ICD implant and atrial fibrillation.
Methods: HCM patients who underwent ICD implantation between January 1988 and December 2005 were included. The frequency of device complications, including pneumothorax, pericardial effusion, haematoma, lead revisions, infection and rate of inappropriate shocks, was determined. ICD shocks were characterised as inappropriate if triggered by sinus tachycardia, atrial fibrillation or device malfunction.
Results: A total of 181 patients were included (mean age 44 (SD 17) years; 62% males). During a mean follow-up of 59 (42) months (4.92 years; 830.75 patient-years), 65 patients (36%) had a total of 88 device complications, including 42 (23%) patients with inappropriate shocks. The rate of inappropriate shocks was 5.3% per year (vs 4% risk of appropriate shocks), and the likelihood of inappropriate ICD shocks per 100 patient-years was 5.1. Younger age and atrial fibrillation were associated with an increased risk of inappropriate ICD discharges.
Conclusions: The rate of inappropriate ICD shocks and frequency of device complications in HCM patients are not insignificant and are most common in younger patients and those with atrial fibrillation. Inappropriate ICD shocks are the most common device complication and should be accounted for when counselling high-risk HCM patients for ICD implantation.
Relevant Article
- Implantable defibrillators in hypertrophic cardiomyopathy
- Andrew Grace
Heart 2009 95: 695-696.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
-
Ommen, S. R., Gersh, B. J.
(2009). Sudden cardiac death risk in hypertrophic cardiomyopathy. Eur Heart J
30: 2558-2559
[Full Text] -
Grace, A.
(2009). Implantable defibrillators in hypertrophic cardiomyopathy. Heart
95: 695-696
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
